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Cytotoxic T lymphocytes execute the killing of insulin-producing beta cells during onset 
of type 1 diabetes mellitus (T1D). The research community has come far in dissecting the 
major events in the development of this disease, but still the trigger and high-resolved 
information of the immunological events leading up to beta cell loss are missing. During 
the past decades, intravital imaging of immune responses has led to significant scientific 
breakthroughs in diverse models of disease, including T1D. Dynamic imaging of immune 
cells at the pancreatic islets during T1D onset has been made possible through the 
development of both advanced microscopes, and animal models that allow long-term 
immobilization of the pancreas. The use of these modalities has revealed a milling 
microenvironment at the pancreatic islets during disease onset with a plethora of active 
players. Clues to answering the remaining questions in this disease may lie in intravital 
imaging, including how key immune cells traffic to and from the pancreas, and how cells 
interact at this target tissue. This review highlights and discusses recent studies, models, 
and techniques focused to understand the immune responses during T1D onset through 
intravital imaging.
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iNTRODUCTiON
Although type 1 diabetes (T1D) has been studied in great detail during the past century, we still 
remain oblivious about many steps in the autoimmune process leading up to near complete beta cell 
destruction and hyperglycemia. Many outstanding questions remain on the events that take place at 
the pancreatic islets during disease onset: how do the immune cells gain access to the islets? How do 
immune cells traffic to the pancreas? How do the different immune cell subsets behave and interact 
with one another at the islets and in draining lymph nodes? How do the immune cells respond to 
therapeutic intervention to prevent or cure autoimmune diabetes?
At the center of the disease lie the islets of Langerhans which harbor the insulin-producing beta 
cells inside miniature (100–300  μm) endocrine organs scattered throughout the pancreas. The 
immune reaction in T1D is focused to these tiny spheroids, and the rest of the pancreas stays rather 
unaffected by the immune attack. The scale and dispersion of the affected tissue and focal inflam-
mation in combination with the retroperitoneal position of the pancreas pose great challenges for 
intravital imaging.
Static imaging (e.g., tissue sections) or flow cytometry will identify differences in functional 
activities if they are large, such as the differential expression of a known protein. In instances where 
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these more profound differences are present between cellular 
subsets, these modalities may be well adequate for analyzing such 
cells. However, when differences are more subtle, e.g., only appar-
ent through the differential behavior of a group of cells, real-time 
imaging would be the modality to distinguish this.
There is great interest in the development of imaging tech-
niques for islets of Langerhans, both experimental and clinical. 
Using imaging as a diagnostic tool for following changes in 
beta cell mass or assessing islet inflammation in patients with 
recent-onset T1D may prove very helpful in early detection 
and understanding of disease kinetics. As an experimental tool, 
imaging immune responses in the pancreas and related lymphatic 
organs has already proven instrumental for understanding of the 
autoimmune events leading up to beta cell loss.
High-resolved real-time imaging of the pancreas has not yet 
been broadly applied to study a wider range of immune cells and 
events in T1D. This focus of this review is to highlight and discuss 
recent studies, models, and techniques focused to understand the 
immune responses during T1D onset through intravital imaging 
of different modalities.
iMAGiNG MODALiTieS
A dream for many immunologists is to be able to follow immune 
cells through the body using an imaging modality that does not 
disturb normal physiology/pathophysiology and that can be used 
to perform longitudinal studies in the same study subject. Even 
though it sounds like an unobtainable fantasy, a few methods do 
come close to fulfilling it; bioluminescence imaging (1), positron 
emission tomography (PET) (2), single-photon emission com-
puted tomography (SPECT) (3), X-ray computed tomography 
(CT), and magnetic resonance imaging (MRI) (4) have some of 
these features. However, for more high-resolved imaging, more 
invasive and less clinically applicable methods, such as intravital 
microscopy, are required.
Bioluminescence imaging
Cells producing bioluminescence will emit light that penetrates 
far through tissue, making non-invasive imaging possible. 
However, luciferase needs to be transgenically expressed in these 
cells, and a secondary imaging modality (e.g., visible light 
camera, X-ray CT, MRI) is required for anatomical informa-
tion. Bioluminescence has been utilized in the field of diabetes 
research by inserting the gene encoding luciferase under control 
by the mouse insulin promoter (MIP) (5) enabling non-invasive 
longitudinal quantification of beta cell mass in the mouse (6). 
Similarly, bioluminescence imaging can also be used for more 
detailed functional assessment of beta cell biology, for example, 
the technique has been used in pancreatic islet transplantation 
research, for assessing the level of hypoxia in the engraftment 
process by expressing luciferase under the control of hypoxia 
response elements (7). With bioluminescence imaging, there are 
limitations to the extent of multiplexing that can be achieved, and 
in most current devices only one single channel of information 
is collected. Even though this modality supports cellular resolu-
tion, the above-mentioned aspects limit the use for this modality 
in more detailed immunological research, and have as such not 
been exploited to a larger extent in autoimmune research. Some 
recent work may point to where this modality could be used in 
inflammation research: a luciferace-based assay was used where 
the interactions of two different chemokine receptors with beta-
arrestin 2, and their activation of signaling can be simultaneously 
assessed in living cells (8), and the trafficking of transgenic T cells 
(9) and luciferase-transfected dendritic cells (10) in the whole 
living animal.
Radiological Techniques
The anatomical location of the pancreas makes it difficult to 
access for a number of imaging modalities. However, radiological 
techniques are in general not to any greater extent limited to tissue 
diffraction (light-based approaches) or direct access to the organ 
of interest (direct imaging approaches). Techniques, such as MRI 
and CT, are widely used in clinics around the world for a variety of 
diagnostic purposes, and are, thus, attractive modalities also from 
a translational perspective. The advent of a robust method for 
assessing islet inflammation using these would provide a bridge 
from bench to bedside, and offer a way of early T1D diagnosis and 
precise disease assessment.
The size and distribution of pancreatic islets puts a high 
demand on spatial resolution for imaging. MRI can achieve a 
resolution on the 0.1-mm scale, just enough to resolve islets in the 
pancreas. However, the modality is put to better use in functional 
imaging, targeting morphological and physiological changes in 
the pancreas during onset of T1D, such as microvascular changes 
in flow, volume, and permeability (11, 12). Specific imaging of 
insulitis has also been successfully explored using MRI. Gaglia 
and colleagues (13) infused dextran-coated magnetic nanoparti-
cles into healthy and T1D subjects. These nanoparticles are read-
ily phagocytosed by macrophages, and are negative T2-weighted 
contrast agents enabling the visualization of areas with a high 
abundance of macrophages, such as inflamed pancreatic islets. 
Non-invasive imaging of insulitis showed a great heterogeneity 
among the subjects, and also confirmed previous data in showing 
that the total pancreas volume is lower in T1D subjects (13).
Magnetic resonance imaging has also been used for the 
visualization of islet grafts following transplantation. Here, the 
possibility of ex vivo labeling the islets for increased detection 
was proven feasible (14). When transplanted in larger clusters, 
islet grafts can be imaged without the use of contrast-enhancing 
agents, as shown in intramuscular transplantation (15).
For a more in-depth assessment immune cell trafficking using 
MRI, ex vivo labeling of immune cells with iron oxide- or 19F-based 
probes is emerging as a powerful way of non-invasively imaging 
leukocyte movement at the whole-animal level (4). It has, to our 
knowledge, yet to be tested in a T1D setting, but could provide 
important information on trafficking of effectors and suppressors 
to, from, and within the pancreas.
Computed tomography is routinely used for imaging retro-
peritoneal organs, such as the pancreas. However, the spatial 
resolution of the modality is too poor to be able to resolve scat-
tered pancreatic islets. CT has, thus, not been employed to a larger 
extent as a solitary imaging modality in imaging for assessing 
T1D progression in the pancreas. CT has been used for imaging 
grafts following whole-pancreas transplantation for assessing 
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vascularity, thrombosis, steatosis, and lymphocyte infiltration. 
These less-detailed points of information help in assessing 
engraftment, but are still too blunt to assess T1D immunology. 
However, with CT as an anatomic delineator in combination 
with a nuclear medicine technique, such as PET or SPECT, an 
increased level of precision can be gained, and an increased 
amount of information can be gathered. Much effort has been 
put into finding beta cell-specific tracers for use in PET/SPECT 
that would provide a way of quantitatively assessing beta cell 
mass in humans. Radiolabeled compounds targeting beta cells 
via insulin granules [e.g., dithizone (16)], ATP-sensitive potas-
sium channels [e.g., glibenclamide (17)], vesicular monoamine 
transporter type 2 [VMAT2, e.g., dihydrotetrabenazine (18)], the 
GLP-1-receptor [e.g., exendin-4 (19, 20)], and agents targeting 
beta cell metabolism [e.g., fluorodeoxyglucose (2, 21)] are among 
the most studied. An accurate method could provide a way of not 
only longitudinally studying beta cell decay in humans, but also 
provide a method for early T1D diagnosis.
Nuclear medicine methods can also be used for detecting 
and following insulitis. Ex vivo labeling of lymphocytes can be 
achieved through the use of agents, such as [111In]oxine (22), 
[111In]tropolonate (23), or [99mTc]hexamethylpropyleneamine 
oxime (24). However, results from both rodent and human studies 
were disappointing, where very little signal from the transferred 
lymphocytes were found in the pancreas. Most labeled cells ended 
up in secondary lymphoid organs, most likely because these sets 
of polyclonal lymphocytes were not activated and too diverse 
in their specificities, leading to very few cells finding their way 
to the islets in the pancreas (25). A more promising approach 
is the radiolabeling of molecules targeting immune cells in vivo. 
One example is the cytokine interleukin-2 (IL-2). Activated 
T cells infiltrating the pancreatic islets during T1D will express 
high levels of the IL-2 receptor and thereby bind and internalize 
large amounts of IL-2. Thereby, the infusion of [123I] labeled IL-2 
permitted the visualization of progressing insulitis in non-obese 
diabetic (NOD) mice (26). For increased flexibility and specific-
ity, moving to radiolabeled antibodies enables the tracking of 
specific immune cell subsets. The Fc-receptor-binding aspects of 
polyclonal IgG’s can be utilized if a less-specific staining is enough 
(27), or the use of, for example, a non-Fc-binding anti-CD3 anti-
body to specifically label T cells (28). A problem common for the 
last few modalities above is the low signal-to-noise ratio emanat-
ing from the fraction of circulating unbound antibodies/protein, 
and the relatively low number of T cells present at the islets in 
human T1D. If these hurdles can be overcome, nuclear medicine 
methods could provide high cellular specificity in research and 
diagnosis of T1D.
Light Microscopy
The simplest and most straightforward way of imaging both static 
tissue samples and dynamic events in live organisms is by merely 
using visible light to illuminate the object and combining this 
with a means of magnifying the area. In the sixteenth century, the 
Dutch spectacle makers Janssen constructed the first compound 
microscope. This was the start of a now 400-year journey deeper 
into the physiology of all living things, culminating in the 2014 
Nobel prize (Betzig, Hell, and Moerner) acknowledging the 
development of super-resolution microscopes, which defy previ-
ous dogmas of the limit of resolution in ingenious ways.
In the area of microcirculation and inflammation, a great body 
of knowledge has been gained during the late nineteenth and 
early twentieth centuries by relatively rudimentary microscope 
setups where, for example, the wings of bats or the tongues of 
frogs were studied through transmitted-light microscopes. With 
the advent of epifluorescence microscopy, scientists were no 
longer limited to translucent tissues for imaging. Using reagents 
capable of emitting fluorescent light, also structures and events 
in more dense organs could be imaged, such as blood flow using 
fluorescently tagged dextran. The major leap in the field came 
with the confocal microscope (29). With this technique, the light 
returning from the epi-illuminated tissue is confined by the use 
of a pinhole or a slit, limiting the collection of photons to only 
a narrow focal plane. Apart from decreasing noise in imaging, 
the optical sectioning feature of confocal microscopy enabled 
three-dimensional reconstructions of the collected data, which 
greatly aids in studying cell-to-cell communications in a tissue 
context. With the development of multiphoton microscopy in the 
1990s (30), a couple of the major drawbacks with confocal laser 
scanning microscopy were avoided; namely high phototoxicity 
and poor tissue penetration (~100 μm). By using a pulsed laser 
that emits light in the far-red to infra-red spectrum (>690 nm), 
normal fluorophores expressed or delivered to the tissue will 
only emit light when they absorb two photons on a very short 
time-scale (10−15 s) in multiphoton microscopy. The probability 
of this occurring in another spot than the focal point is very low, 
limiting excitation of the tissue to a very small area. The longer 
laser wavelengths used in multiphoton microscopes also reduces 
the amount of energy transferred to the tissue, decreasing the risk 
of phototoxicity, and increases the penetration depth (~500 μm) 
due to decreased light-scattering effects in tissue. The increased 
penetration depth offered by multiphoton microscopy is a great 
advantage to visible-light confocal microscopy when imaging 
islets in the pancreas. With a normal confocal microscope, the 
microscopist is limited to islets situated at the very surface of the 
pancreas, limiting the selection of tissue to be studied. Increasing 
the penetration depth by only a few hundred micrometers will 
greatly increase the numbers of islets that are reachable for the 
microscope. Other features of multiphoton excitation are second 
(two-photon excitation) and third (three-photon excitation) har-
monic generations. In these, multiple photons interact with tissue 
constituents and create a resulting photon of two or three times 
the initial energy, respectively. This enables label-free imaging of 
collagen and myosin fibers [second harmonic generation (31)], 
and lipid layers and myelin fibers [third harmonic generation 
(32)]. In combination with the collection of reflected laser light, 
multiple channels of morphologic information of the tissue can 
be collected without the use of fluorescent dyes.
A few modalities have emerged recently that expand the pos-
sibility to collect more information from intravital microscopy 
preparations. Coherent anti-Stokes Raman scattering (CARS) 
uses two laser beams to investigate the energy gap between 
two vibrational levels of a studied molecule. This modality has 
proven useful for imaging myelin fibers and lipid layers (33–35). 
Fluorescence lifetime imaging (FLIM) interrogates the time a 
TABLe 1 | Methods for intravital microscopy of immune responses in 
pancreatic islets.
In situ in the pancreas
In peritoneum Hellerstrom and Hellman (50), McCuskey and 
Chapman (51), and Rooth et al. (52)
Exteriorized on pedestal Martinic and von Herrath (53) and  
Coppieters et al. (54)
Suction ring Lindsay et al. (55)
Transplanted
Dorsal skin fold Menger et al. (56)
Striated muscle Christoffersson et al. (15)
Anterior chamber of the eye Speier et al. (57)
Under the kidney capsule Bertera et al. (58)
Greater omentum Espes et al. (59)
Live explants
Isolated islets Friedman et al. (60)
Sectioned pancreas Marciniak et al. (61)
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molecule spends in an excited state, and can give quantitative 
information on parameters, such as ion concentrations, pH, 
metabolic states, and oxygen levels (36–38).
Live CeLL AND iNTRAviTAL iMAGiNG
High-Resolution intravital imaging of 
immune Responses
The increased accessibility to laser scanning confocal micro-
scopes in the 2000s spurred a surge in new discoveries and 
insights into immunological events. This was also fueled by the 
concurrent development of imaging tools, such as fluorescent 
proteins, the development of which was awarded the Nobel prize 
in 2008 (Chalfie, Shimomura, and Tsien). Mouse models where 
certain immune cell subsets express fluorescent reporter genes 
have led to discoveries that were unlikely to occur without the 
use of high-resolved imaging. One example is the widely used 
Cx3cr1GFP reporter mouse, where predominantly monocytes and 
macrophages are tagged with the fluorescent protein (39). This 
reporter mouse has revealed many secrets held by these myeloid 
cells, including a previously unappreciated vast distribution of 
resident macrophages (40), and the subsetting and exposure of 
dual functions of monocytes (41, 42).
The most common organs to image in immunological questions 
are lymphoid organs, such as draining lymph nodes and the spleen. 
These organs are not only highly relevant sites for the integration 
of immunological signals but are also relatively uncomplicated to 
image. They require minimal surgery [e.g., a skin flap for inguinal 
or cervical lymph node (43), or the ear (44)], and can even be 
imaged ex vivo as explants in heated chambers with satisfying 
results [e.g., vibratome-cut spleen (45)]. The introduction of the 
multiphoton microscope and its improved imaging depth further 
increased the ability to interrogate questions in lymphatic organs. 
Intravital microscopy in the field of immunology has not just put 
images on processes that were already know, but has proved to 
be a very powerful tool to unveil interactions and movements 
that were impossible to uncover without direct microscopy. We 
now know that leukocytes crawl within vasculature (42, 46), that 
intraperitoneal macrophages invade the damaged liver (47), that 
there is a very intricate interplay between B cells and T helper cells 
in germinal centers (48), and the swarming behavior of innate 
leukocytes when tissue is damaged (44, 49).
intravital imaging of the Pancreas
Due to its retroperitoneal location and its fragility in vivo imaging 
of the pancreas poses difficulties on the operator performing the 
imaging. In particular, the scattered distribution of the islets of 
Langerhans puts high demands on the tools used for imaging for 
allowing both deep tissue imaging and the ability to keep a single 
islet in focus for extended periods of imaging.
When performing intravital microscopy imaging on small 
animals, normal physiology will in one way or another be dis-
turbed. The surgery involved will provoke some inflammation 
and fluid leakage. Materials used to immobilize the animal or 
organ may disrupt blood flow or function as heat sinks if made of 
a conductive material. The sedated state of the animal, including 
off-target effects from the anesthetics, will render issues with 
temperature regulation. Also laser illumination of the sample 
can cause heating of the tissue or other forms of phototoxicity, 
such as cell damage due to the generation of free oxygen radicals. 
Measures should, thus, be taken to support normal physiology to 
as large extent as possible, from heating pads under the animal 
to the monitoring of blood pressure, and monitoring of tissue 
perfusion in the organ studied to be able to achieve reproducible 
and true results.
All of the parameters mentioned above need to be taken into 
account when performing imaging of the live pancreas or islets 
transplanted elsewhere. A number of different methods for imag-
ing islets in the living rodent have been published over the years 
(Table 1). Common to all methods is the ambition to create a state 
where the tissue is as isolated as possible from respiratory and 
cardiac movements, while still maintaining undisturbed blood 
perfusion, moisture, and temperature.
Intravital fluorescence imaging of the physiology of the pan-
creas and the islets of Langerhans has been performed since the 
1960s (50) when Hellerstrom and Hellman did their intravital 
observations on the islet blood flow in situ. The early fluorescence 
microscopy studies by Rooth and colleagues in the 1980s showed 
the usefulness of direct microscopy of dynamic events in pan-
creas physiology (52), as their observations of a “stop-and-go” 
blood flow in islets following norepinephrine infusion explained 
why two other groups had obtained opposing results (62, 63). 
Investigations of, for example, the vascular network, blood flow, 
and leukocyte recruitment do not require advanced microscopes 
(i.e., wide-field trans/epi-illumination microscopes), but renders 
the researcher to be limited to islets that are superficially situ-
ated and easily distinguished. More recently, Nyman et al. (64) 
used the three-dimensional power of the confocal microscope 
to answer the long debated question of blood flow direction in 
pancreatic islets of the mouse. They found two distinct blood flow 
patterns: one “inner-to-outer” and one “top-to-bottom” direction 
of flow (64).
Due to anatomical and microscopy technical issues, it was 
not until 2010 detailed intravital observations of the immune 
response during onset of T1D were first made. Coppieters 
et al. had developed a model where the pancreata of mice were 
exteriorized and kept warm and moist on a viewing pedestal for 
FiGURe 1 | examples of intravital and live cell imaging methods for T1D research. (A) The pancreas can be exteriorized and fixed to a viewing pedestal for 
motion-artifact free imaging. In this particular setup, the mouse and pancreas are kept warm by body-temperature water circulating in the metal tubing. The 
pancreas is kept moist by being submerged in physiologic saline buffer. For more details, see Ref. (54). The suction ring pictured in (B) allows for the pancreas to 
remain in the abdominal cavity while immobilizing a small part of the tail region to a circular coverslip for intravital imaging. For more details, see Ref. (55, 66). If more 
advanced manipulation of the tissue is needed or intravital microscopy is otherwise impossible, thick, live sections of the pancreas in a warm imaging chamber 
(C) can be an alternative to in vivo methods. For details, see Ref. (67). If only pancreatic islets are available or required for the research questions, immobilization in 
agarose gel and placement in a warm imaging chamber (D) can provide live cell imaging. For details, see Ref. (55).
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confocal/multiphoton imaging (53, 54). Since, in this model, the 
pancreas was exteriorized and attached to a foundation, it was 
isolated from respiratory artifacts from the mouse (Figure 1A). 
In comparison to former in  situ imaging models, this allowed 
for imaging a larger area of the pancreas (albeit biased to the tail 
region of the organ). In combination with multiphoton imaging 
and fluorescent reporter mice, this model revealed new insights 
into the dynamics of cytotoxic T lymphocyte (CTL) trafficking 
and actions in the pancreas during beta cell killing (65).
A leap forward in intravital microscopy imaging of several 
different organs of the mouse was made with the development of 
a suction window where the organ of interest is kept in a stable 
position under a coverslip by some gentle vacuum [Figure  1B 
(66)]. The method was first developed for imaging the lung, but it 
has proven useful for a wide range of other organs, including the 
pancreas (60). The advantages that the suction window offered 
were an increased stability during imaging, as a small part of the 
pancreas is held steady by the vacuum, and that the pancreas can 
remain in its native location in the peritoneal cavity. Access to the 
tissue only requires an incision in the left peritoneal wall, small 
enough to fit the suction device, resulting in minimized fluid loss 
and an increased ability to maintain euthermia in the organ. The 
device is also small, and can be 3D-printed in a plastic material, 
offering customizability to a very low price. Some computer-
aided design (CAD) drawings of different ring designs have 
been deposited online for free download from the University of 
California, San Francisco, CA, USA (http://biomicroscopy.ucsf.
edu).
The above-mentioned methods do, however, not allow for 
longitudinal imaging of the same pancreas in the same animal. 
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The surgical procedures surrounding these imaging techniques 
require the experiments to be terminal. A solution could be the 
surgical implantation of an abdominal imaging window (68). To 
our knowledge, this has yet to be proven successful in imaging 
the progress of T1D in pancreatic islets in  situ, but implanted 
body windows have provided useful longitudinal data from other 
abdominal organs (69) and tumors (70).
A sidetrack from intravital imaging is live cell imaging of 
tissue explants. Even though this is a step far from the in  vivo 
situation where the tissue lacks vital components, such as blood 
flow, influx of immune cells, lymphatic drainage etc., it might still 
be useful for some questions in immunology. Imaging of T cell 
motility in isolated islets from NOD mice placed in an agarose 
gel (Figure  1D) was successfully performed by Lindsay et  al. 
(55). This group also performed intravital imaging of the same 
events to validate the method by correlating in  vivo migration 
data to that from explanted islets. Arguments for performing this 
type of explant imaging as compared to intravital imaging are 
the increased number of islets that can be imaged per pancreas 
used, that lower-intensity fluorescent reporters, such as biosen-
sors, can be used, and that an increased level of manipulation 
of the tissue can be introduced. Drawbacks include the fact that 
only immune events within the islets are recorded, when much 
of the dynamics of T cell migration and interactions may occur 
in the islet periphery. The isolation of islets also induces stress, 
and limits the study to fairly intact islets, and not islets in more 
advanced stages of destruction as these would not survive tissue 
digestion protocols.
Even though the method has not yet been proven for immu-
nological questions, the use of thick, live slices of pancreata 
may be a way of performing live cell imaging when an increased 
level of manipulation is required (Figure 1C), or when the tis-
sue comes from large animals, such as pigs and non-human 
primates or even donated human pancreata. Marciniak and 
colleagues (67) embedded pancreatic tissue in agarose gel 
and then used a vibratome to cut thick slices (150 μm) of the 
tissue in a minimally disruptive way. As a proof of concept 
for the usefulness of the model in islet physiology, the group 
performed calcium imaging of beta cells in the pancreas slices 
using a genetically encoded calcium indicator (67). A model 
such as this also opens up for more advanced manipulation of 
the tissue, including that related to immune cells, such as patch-
clamping and other electrophysiological and neurophysiologi-
cal experimentation.
Common to most intravital microscopy modalities are 
the large quantities of data that are gathered for each experi-
ment. Confocal and multiphoton microscopes provide four-
dimensional information (three spatial dimensions plus time) 
(Figure  2). This in combination with multicolor imaging over 
extended periods of time renders several gigabytes of data per 
day in a microscopy-focused lab. Good routines for data storage 
and handling are important. Important are also the softwares 
used for analyzing the recorded images. Well-written scripts 
can simplify the extraction of valuable data from 4D movies. 
A number of high-performing alternatives exist, several with 
a full- or semi-open source profile for researchers to write and 
share their own scripts, macros, and add-ons. A recent example 
is the merge of flow cytometry-type of data visualization with 
imaging software (71).
intravital imaging of Transplanted islets
A way of circumventing the difficulties involved in direct intra-
vital microscopy of the pancreas has been to isolate pancreatic 
islets and to syngeneically transplant them elsewhere in the body 
where imaging could more readily be performed. Examining islet 
physiology by imaging them at a different site than the pancreas 
was pioneered by Menger and colleagues in the 1980s (56). This 
group investigated the regulation of microvascular blood flow 
and angiogenic capacities of the islets transplanted into a dorsal 
skin fold (72). Others have imaged the engraftment and revascu-
larization of islets in the context of curative transplantations (15), 
and used islets transplanted to muscle as a model for studying 
non-tumoral angiogenesis (73). Pancreatic islets and pancreatic 
tissue have been transplanted to the anterior chamber of the eye 
for experimental studies for a long time (74). However, it was not 
until Speier and colleagues combined the technique of inserting 
islets into the eye of rodents with advanced intravital microscopy 
that a powerful tool for studying the islet engraftment process 
and subsequently beta cell biology in an in vivo setting emerged 
(75). The main advantage of this model is the non-invasive way 
of imaging islets through the eye of the animal. The cornea acts 
like a natural body window and allows for longitudinal imaging of 
the same islet over the course of the animal’s life. The eye has also 
been proven not to be a completely immune privileged site when 
it comes to allorejection (76) and autoimmune destruction (77) 
of the beta cells. Another method that also provided longitudinal 
imaging of islets was the body-window method described by 
Bertera et al. (58). The authors transplanted fluorescence trans-
genic islets under the kidney capsule of mice and inserted a body 
window to be able to view the islets repeatedly over time.
Even though the methods described above provide elegant 
solutions to imaging the immune responses at islets during onset 
of T1D, careful consideration of how the microenvironment has 
changed has to be done before extrapolation of the results can be 
made to be true also for the pancreas. Differences in migration 
substrates for the immune cells (78), lymphatic drainage (79), or 
populations of resident leukocytes (80) can all affect the nature of 
the immune response targeted to the beta cells.
iNTeRROGATiONS iN T1D ReQUiRiNG 
iNTRAviTAL iMAGiNG
Many questions remain unanswered in autoimmune diabetes 
and great efforts are under way to provide new insights into 
this enigmatic disease. Prospective cohorts, genetic analyses, 
epidemiologic datamining, and other large projects are set to 
contribute some of these, but to get to the core of the causative 
events of T1D, a deep look into the events that take place at the 
islets of Langerhans before and during beta cell destruction might 
be what holds the key to a cure.
With the work performed by Coppieters et  al. (54, 65), we 
now have a much better view of some of the T cell trafficking 
events that take place during onset of experimental autoimmune 
diabetes. With the use of a mouse model [LCMV.RIP-GP (81)] 
FiGURe 2 | Multicolor intravital confocal imaging of the pancreas. Examples of still-frames from intravital microscopy imaging of the pancreas in healthy 
control mice (top row) and diabetic (LCMV.RIP-GP) mice (middle and lower rows). Macrophages are visualized by their expression of GFP at the CX3CR1 locus 
(green). Adoptively transferred antigen-specific P14 T cells express the fluorescent DsRed protein. Pancreatic islets and parenchyma are visualized by laser 
reflection. Notice the difference in reflective signal as the beta cells are killed and enter apoptosis. Blood vessels are visualized by the injection of a fluorescently 
tagged anti-CD31 antibody. Four-dimensional data (three spatial dimensions plus time) is collected and used for software tracking of cell movements and the 
interactions between T cells and beta cells, and T cells and antigen-presenting cells. The type of migration can be distinguished by plotting mean displacement to 
the square root of time. The three lines represent random/Brownian movement (black), confined movement (green), and directional movement (blue).
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where a well-defined autoantigen is transgenically presented on 
the surface of beta cells, and fluorescent antigen-specific CD8+ 
T cells (P14), the antigen-governed immune response at the islets 
could be tracked. These studies showed that CTL gain access to 
the pancreas via extravasation through postcapillary venules and 
freely migrate through the pancreas in a random-walk fashion. 
These observations suggest that there are no apparent barriers for 
the CTLs in the mouse pancreas as has been suggested in other 
studies (82), but they move freely in and out of the islets with no 
time-lag at the islet–exocrine interface.
Tracking of antigen-specific T cells in intravital recordings is 
readily done by using an artificial and transgenic system, such 
as the RIP-GP/P14/Smarta model mentioned above, or the 
RIP-mOVA/OT-I/OT-II model (83). The adoptive transfer of 
fluorescent CD4+ and/or CD8+ T cells from T cell receptor (TCR) 
transgenic mice, specific for an antigen expressed on the beta cells, 
enables the tracking of islet-specific cells throughout the body. To 
our knowledge, there is currently no way of tracking naturally 
antigen-specific cells in a spontaneous and multi-antigenic model 
of T1D, such as the NOD mouse. Peptide–MHC multimers are 
routinely used to find antigen-specific cells by immunofluores-
cence or flow cytometry, but their use in intravital microscopy is 
most likely hindered by dose/price, low binding efficiency in vivo, 
and low signal when bound to their specific TCR.
Even though the intravital studies discussed above provided 
new insights into T cell trafficking to and within the pancreas, it 
is still to a large extent uncertain what role antigens play in the 
accumulation of CTLs at the islets. Many of the T cells found 
at islets in both mouse models (84) and human T1D pancreata 
(85) are not specific to known islet antigens. Other signals may, 
thus, be involved in the recruitment of T cells to the islets, such as 
chemokines and cytokines, and the pathogenic role and behavior 
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of these non-antigen-specific bystander T cells are unknown. 
Intravital microscopy could provide clues to the behavior and 
significance of these bystander T cells.
Intravital imaging of the pancreas during onset of T1D also 
holds the possibility to reveal details on lymphocyte trafficking 
on a larger scale. Even though they did not perform intravital 
imaging, Magnuson et  al. (86) had an elegant approach to 
attempt to delineate the whole-body trafficking of antigen-
specific and polyclonal lymphocytes in the NOD mouse. 
By using cells from the transgenic Kaede mouse (87), which 
carries a photoswitchable protein, the authors could shine an 
ultraviolet light on cervical lymph nodes and thereby track 
the color-converted cells throughout the mouse body by flow 
cytometry. Also, this study found the islets to be “open” to 
both antigen-specific and non-antigen-specific T cells, as both 
types trafficked to and from the pancreas to similar extents. 
The intravital imaging study by Lindsay et  al. (55) came to a 
similar conclusion regarding the governance of antigen over the 
behavior of T cells. In this study, there was, however, a slight 
shift in the local behavior of antigen-specific CD4+ T cells with 
time and the progression of islet infiltration. These cells arrested 
and interacted to a larger extent with antigen-presenting cells 
at early compared to later stages of disease (55). The study 
was not able to explain this shift in behavior, but it might be 
influenced by the major change in microenvironment that the 
progressive massive infiltration of T cells constitutes. The two 
studies discussed in this paragraph take either a whole-body- or 
an islet-focused approach to T cell trafficking. What is lacking 
in the literature is data on the migration of T cells and antigen-
presenting cells from the islets to the pancreatic draining lymph 
nodes and the importance of this flux of cells. Incorporating a 
lymphatic stain or a lymphatic genetic fluorescent reporter in 
intravital pancreas imaging could reveal key steps in early local 
trafficking events in autoimmune diabetes.
A cell type of great interest in autoimmunity and the focus 
of many-a-study study in this field is the regulatory T cell 
(Treg). The potentiation of Treg activity holds the promise of 
suppressing the immune system in a wide range of diseases 
(88), and is also being explored in the treatment of patients with 
recent-onset T1D (89). The T cell trafficking study by Magnuson 
and colleagues (86) also included Tregs in their analyses. It was 
found that Tregs were slow in exiting peripheral lymph nodes 
and slow in migrating to the pancreas, which may explain the 
decreasing proportion of Tregs in islets as T1D progresses. Tregs 
are just not repopulating islets in the same rate as conventional 
T cells are (86). Tregs have been imaged in the pancreatic drain-
ing lymph nodes of NOD mice (90), and in islets transplanted 
to the anterior chamber of the eye of NOD mice (91), but to our 
knowledge never directly in the living pancreas. The graft study 
revealed intense interactions between Tregs and effector T cells 
(91), whereas the lymph node study found much interactions 
between antigen-presenting cells and Tregs (90). The interac-
tions between Tregs and effector T cells at islet grafts were 
independent of the local presence of an antigen-presenting cell 
(91), which makes it even more interesting to see whether there 
is a similar local immune suppression in the pancreas, and how 
Tregs behave and migrate in the pancreas.
B lymphocytes have been shown to be involved in both human 
T1D (92) and mouse models of autoimmune diabetes (93). Even 
though they are not abundant in the pancreas in the mouse dur-
ing T1D, their interplay with other infiltrating lymphocytes at the 
islets has, to our knowledge, not been explored, and may be one of 
many aspects of the islet immune environment to be interrogated 
by intravital microscopy.
In vivo microscopy of the human pancreas has, to our 
knowledge, not been performed to date, and is obstructed by 
the numerous limitations mentioned above that the pancreas 
imposes on anyone that attempts a surgical procedure on the 
organ. However, technical progress may in the future lead to 
high-resolution optical imaging of the islets during T1D onset. 
A recent report describes a human intravital setup for studying 
melanomas (94). Imaging the pancreas with a similar setup would 
require invasive surgery, but the development of more advanced 
confocal laparoscopes (95) may enable minimally invasive imag-
ing of immune responses. Until then, animal models alongside 
ex vivo preparations of human pancreata (67) provide the best 
models of studying immune cells at the islets to understand the 
chain of events during onset of T1D.
CONCLUSiON
The development of in  vivo imaging of the pancreas and the 
immune response during autoimmune diabetes holds great 
promise for both clinical aspects and preclinical research of T1D. 
Imaging the beta cell mass non-invasively with great precision in 
patients with T1D would not only provide a tool for early disease 
detection and/or detection of persons at risk, but could also 
provide researchers with invaluable data on the natural course of 
events of a disease that affects an organ that is very hard to reach 
for imaging or biopsies.
Imaging islet inflammation in the T1D patient is, however, 
even more difficult, even if it already has been explored by 
targeting macrophages. Intravital imaging of murine pancre-
atic islets in  situ, transplanted elsewhere, or as explants, has 
provided the research community with great insights into islet 
physiology, the immune events during beta cell destruction, 
and the trafficking of immune cells. The microenvironment that 
the pancreas holds for the islets and the resident and infiltrat-
ing immune cells has repeatedly been shown to have special 
properties, and should thereby not be neglected when imaging 
immune responses in T1D.
Much remains to be learnt in this disease, and intravital 
microscopy is a powerful tool to help answer many questions. 
With the advent of new microscopy techniques (increased 
resolution, more channels of data), new genetic reporters (bio-
sensors, photoswitchable proteins), and ways of tissue manipula-
tion (optogenetics, sonogenetics), we may soon be able to get 
the complete picture of T1D, a picture that currently lacks in 
resolution.
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